Foghorn Therapeutics Inc. to Participate in Citi's Biopharma Back to School Summit

Reuters
2025.08.27 11:00
portai
I'm PortAI, I can summarize articles.

Foghorn Therapeutics Inc., a clinical-stage biotechnology company, will participate in Citi's 2025 Biopharma Back to School Summit on September 3, 2025. The management will hold one-on-one meetings during the event. This announcement is for informational purposes only and should not be considered financial or legal advice.

Foghorn Therapeutics Inc., a clinical-stage biotechnology company focused on treating serious diseases through correction of abnormal gene expression, is set to participate in Citi’s 2025 Biopharma Back to School Summit. The event will take place on Wednesday, September 3, 2025, where the management will engage in one-on-one meetings. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Foghorn Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9517687-en) on August 27, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.